Not finding it? Sign in to also search OpenAlex live.
-
Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia: A Systematic Review and Meta-analysis2020 Schizophrenia Bulletin Open review Medicine Schizophrenia research and treatment Open access cited by 1 patent
Jan P.A.M. Bogers, George Hambarian, Maykel Michiels, Jentien M. Vermeulen, Lieuwe de Haan
33citations -
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction2020 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Robert Landewé, Désirée M F M van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip E Van den Bosch, Karl Gaffney, +6 more
73citations -
Dose reduction and discontinuation of biologic and targeted synthetic disease-modifying anti-rheumatic drugs (DMARDs) in people with axial spondyloarthritis and low disease activity2021 Cochrane Database of Systematic Reviews article Medicine Spondyloarthritis Studies and Treatments Open access
Jodie Avery, Samuel Whittle, Renea V Johnston, Liesl Grobler, Bayden J McKenzie, Sheila Cyril, +2 more
0citations -
Pharmacokinetic-guided dose reduction of emicizumab in congenital hemophilia A: interim analysis of the DosEmi study2025 Journal of Thrombosis and Haemostasis article Medicine Hemophilia Treatment and Research Open access
Konrad van der Zwet, Marjon H. Cnossen, Floor C. J. I. Heubel-Moenen, Saskia E.M. Schols, Paula F. Ypma, Paul L. den Exter, +41 more
8citations -
Reduction of organ of interest dose in proton therapy for oesophageal cancer through optimized setup robustness settings and online adaptation2026 Physics and Imaging in Radiation Oncology article Physics and Astronomy Advanced Radiotherapy Techniques Open access
Eva van Weerd, Anne Lisa Wolf, Steven Habraken, Yvonne L.B. Klaver, Mischa S. Hoogeman
0citations -
Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial
Celia A J Michielsens, Nadine Boers, Nathan den Broeder, Mark H. Wenink, Aatke van der Maas, Elien A. M. Mahler, +5 more
21citations -
T246. RISK FACTORS FOR PSYCHOTIC RELAPSE IN CHRONIC SCHIZOPHRENIA AFTER DOSE-REDUCTION OR DISCONTINUATION OF ANTIPSYCHOTICS: A SYSTEMATIC REVIEW AND META-ANALYSIS2020 Schizophrenia Bulletin conference-abstract Medicine Schizophrenia research and treatment Open access
Jan P.A.M. Bogers, George Hambarian, Jentien M. Vermeulen, Lieuwe de Haan
2citations -
OP0261 TREAT-TO-TARGET DOSE REDUCTION AND WITHDRAWAL STRATEGY OF TNF INHIBITORS IN PSORIATIC ARTHRITIS AND AXIAL SPONDYLOARTHRITIS: A RANDOMIZED CONTROLLED NON-INFERIORITY TRIAL2022 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
C. Michielsens, N. Den Broeder, Frank H J van den Hoogen, E. Mahler, S. Teerenstra, Désirée van der Heijde, +2 more
0citations -
Reply to: Dihydropyrimidine Dehydrogenase Enzyme-Guided Dosing of 5-Fluorouracil: Prioritizing Precision Over Dose Reduction2025 JCO Precision Oncology letter Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access
Helle-Brit Fiebrich-Westra, Christina Haroun, Daphne den Besten-Bertholee, Maarten J. Deenen, Dirk Jan A. R. Moes, Pierre M. Bet, +4 more
0citations -
Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial2022 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Celia A J Michielsens, Nathan den Broeder, Frank H J van den Hoogen, Elien A. M. Mahler, Steven Teerenstra, Désirée M F M van der Heijde, +2 more
35citations -
OP0103 DOES GENDER, AGE OR SUBPOPULATION INFLUENCE THE MAINTENANCE OF CLINICAL REMISSION IN AXIAL SPONDYLOARTHRITIS FOLLOWING CERTOLIZUMAB PEGOL DOSE REDUCTION?2020 Annals of the Rheumatic Diseases conference-abstract Medicine Spondyloarthritis Studies and Treatments Open access
R. B. M. Landewé, Désirée M F M van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip E Van den Bosch, Karl Gaffney, +5 more
1citations -
Review of dose setting for the extended one-generation reproductive toxicity studies (OECD TG 443): Considerations on ECHA's dose level selection recommendations2024 Regulatory Toxicology and Pharmacology article Veterinary Animal testing and alternatives Open access
Manon E. W. Beekhuijzen, Jason C. Manton, Pragati Sawhney Coder, Katy O. Goyak, Rashin Ghaffari, Susan L. Makris, +3 more
9citations -
Lower Risk of Recurrence with a Higher Induction Dose of Mesalazine and Longer Duration of Treatment in Ulcerative Colitis: Results from the Dutch, Non-Interventional, IMPACT Study2022 Journal of Gastrointestinal and Liver Diseases article Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease Open access
Rachel Louise West, Maurice G. Rüssel, Alexander G L Bodelier, Johan P. Kuijvenhoven, Karlien F. Bruin, Jeroen M. Jansen, +12 more
11citations -
Prediction of dose reductions and impact of reduced starting doses of CDK4 /6i on effectiveness in HR ‐positive/ HER2 ‐negative metastatic breast cancer: Real‐world data from the OPAL registry
Patrick Marschner, Marc Thill, Mark‐Oliver Zahn, Anja Welt, Arnd Nusch, Gabriele Kaltenecker, +13 more
3citations -
P0810DOSAGE REDUCTION OF LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH RENAL DYSFUNCTION: EFFECTS ON ANTI-XA LEVELS AND CLINICAL OUTCOMES2020 Nephrology Dialysis Transplantation article Medicine Venous Thromboembolism Diagnosis and Management Open access
Paul Hornung, Meriem Khairoun, Friedo Wilhelm Dekker, Karin A. H. Kaasjager, Albert Huisman, Lily Jakulj, +4 more
0citations